These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice.
    Author: Ito H, Komaki R, Milas L.
    Journal: Int J Radiat Oncol Biol Phys; 1994 Mar 01; 28(4):899-903. PubMed ID: 8138443.
    Abstract:
    PURPOSE: The study was designed to investigate the ability of S-2-(3-aminopropylamino) ethylphosphorothioic acid (WR-2721) to protect mouse colon mucosa against damage produced by the combined radiation plus cis-diamminedichloroplatinum II (cis-DDP) treatment. METHODS AND MATERIALS: The mucosal damage was quantified by using microcolony assay, which measures the survival of epithelial cells in colon crypts. Radiation doses ranged from 8-24 Gy gamma rays. Cis-diamminedichloroplatinum at a dose of 13 mg/kg and WR-2721 at a dose of 400 mg/kg body weight were given IP before or after irradiation. RESULTS: Addition of cis-DDP to radiation within 24 h before and 48 h after irradiation reduced the number of crypt cells more than did radiation alone. The highest reduction was seen when the drug was given 2 or 6 h before irradiation: the damage was increased by a factor of 1.5. Protective effects of WR-2721 were tested in the radiation plus cis-DDP combination in which cis-DDP was given 2 h before or 2 h after radiation. In the former sequencing, WR-2721 was given 30 min before radiation (90 min after cis-DDP); damage was reduced more than the amount of damage contributed by cis-DDP (PF = 1.6). When cis-DDP was given 2 h after irradiation, WR-2721 was administered 30 min either before irradiation or 30 min before cis-DDP. Here, the protective effect was achieved only when WR-2721 was given before radiation: the PF was 1.3 in that case and only 1.1 when WR-2721 was given before cis-DDP. Thus, WR-2721 must be given before irradiation, but even then the degree of protection achieved depends on whether cis-DDP is applied before or after irradiation, with the protection being greater in the former situation. CONCLUSION: Our observations showed that WR-2721 is a potent protector against the injury of mouse colon mucosa produced by the combined radiation plus cis-DDP treatment. They have important implications in the clinic, indicating that proper timing of WR-2721 administration is crucial for preventing side effects of the cis-DDP and radiotherapy combination, where damage to mucosal epithelial cells is dose limiting.
    [Abstract] [Full Text] [Related] [New Search]